APOBEC3G and cancer: Although involvement of APOBEC mutagenesis in cancer has only recently come to light, these enzymes have been a focus of virology research for over a decade, beginning with the near simultaneous discoveries of APOBEC3G (A3G) as an HIV-1 restriction factor and as a DNA cytosine deaminase [14, 15] (reviewed elsewhere [16, 17]).